Enke Bashllari

N

Board Observer

Nanite

Jul 2022 - Current (3 years 6 months)

Nanite is a biotech company developing a new class of polymer nanoparticles for non-viral gene delivery. The company’s AI-driven platform SAYER™, combines high throughput experimental and computational methods to design delivery vehicles with tissue specificity for a variety of genetic medicines.

C

Investor

Canaery

Mar 2022 - Current (3 years 10 months)

Canaery is an early stage biotechnology company engaged in developing a revolutionary ultra wide-band chemical sensor and analytics network.

Investor

CULINA HEALTH

Jan 2022 - Current (4 years)

Culina Health is a personalized, tech-enabled nutrition platform powered by registered dietitians to help you prioritize the way you want to live.

C

Investor

Cofertility

Dec 2021 - Current (4 years 1 month)

Cofertility is building a human-first fertility ecosystem that empowers everyone to own their own family-building timeline and journey.

S

Investor

Sollis Health

Nov 2021 - Current (4 years 2 months)

Sollis Health offers elite care via 24/7 concierge medical centers that handle emergencies, everyday checkups, and everything in between.

Investor

CertifyOS

Nov 2021 - Current (4 years 2 months)

CertifyOS is an API-first, UI agnostic, end-to-end network management platform for provider credentialing, enrollment, monitoring and licensing.

H

Investor

Handspring Health

Sep 2021 - Current (4 years 4 months)

Handspring Health provides quality and evidence-based mental healthcare for children.

F

Limited Partner

First Close Partners

Jul 2021 - Current (4 years 6 months)

First Close Partners backs venture funds owned by underrepresented managers helping them get to a “first close.” We invest in venture capital firms owned and operated by managers who are people of color, women, LGBTQIA+, indigenous people, people with disabilities, and members of other groups that have been historically underrepresented, especially in the venture capital industry.

N

Investor

Novost

Jul 2021 - Current (4 years 6 months)

NOVOS is a human longevity company offering science-based and data-driven nutraceutical supplements and tests to address aging.

E

Investor

Elaborate

Apr 2021 - Current (4 years 9 months)

Elaborate is the platform doctors use to send lab results, providing patients with clarity on what the results mean and what to do next.

Q

Investor

QSimulate

Mar 2021 - Current (4 years 10 months)

QSimulate revolutionizes industry R&D with innovative quantum simulations to make meaningful contributions to the drug discovery process.

C

Investor

Connie Health

Dec 2019 - Current (6 years 1 month)

Connie Health empowers older Americans via their Medicare consumer platform combining a tech-driven recommendation engine with local agents for personalized plan and healthcare navigation.

D

Strategic Advisory Board

Digital Medicine Society DiMe

May 2019 - Current (6 years 8 months)

The Digital Medicine Society (DiMe) is a professional society serving individuals at the intersection of global healthcare and technology. DiMe supports the development of digital medicine through international interdisciplinary collaboration, research, teaching, and the promotion of best practices.

Investor (Exited)

HumanFirst

May 2019 - Current (6 years 8 months)

HumanFirst is building the operational infrastructure to support decentralized trials and virtual care at home. Exited as M&A to ICON Plc (NASDAQ: ICLR)

P

Board Of Directors

Paradromics Inc

Feb 2018 - Apr 2021 (3 years 3 months)

Paradromics is bringing to market a high-bandwidth brain machine interface, which will enable patients with debilitating disorders such as ALS or paralysis to reconnect with the outside world.

P

Investor

Paradromics Inc

Feb 2018 - Current (7 years 11 months)

M

Investor

Medivis

Apr 2017 - Current (8 years 9 months)

M

Investor and Advisory Board

MediVis Inc

Apr 2017 - Dec 2020 (3 years 9 months)

MediVis is bringing augmented reality, computer vision and machine learning to the operating room.

T

Investor

Tia

Mar 2017 - Current (8 years 10 months)

Tia is the modern medical home for women. The company is trailblazing a new paradigm for women’s healthcare that treats women as whole people vs. parts or life stages.

A

Founder and Managing Director

Arkitekt Ventures

Jan 2017 - Current (9 years)

Arkitekt Ventures is an early stage venture firm, with a mission to improve and advance human health. We partner with exceptional founders building the next generation of Health & Bio companies.

Investor, Board Observer & Advisor

Parsley Health

May 2016 - Current (9 years 8 months)

Parsley Health is a holistic national medical practice, best described as the future of chronic care management.

P

$1M ALS Therapeutic Prize

PrizeLife Inc

Jun 2015 - Aug 2015 (3 months)

Evaluated the commercial viability and scientific merit of the submissions for the $1M Prize. P4L's $1M Therapeutic Prize was established to advance discovery of treatments for ALS, a terminal neurodegenerative disorder.

R

Co-founder shifted to Advisory role

RAW IS EVERYTHING

Dec 2014 - Dec 2016 (2 years 1 month)

RAW IS EVERYTHING is a 100% organic, scientifically backed, skincare brand sold at national luxury retailer Bluemercury and clean beauty Follain stores. The company was conceived as part of a project/required curriculum for all first-year Harvard Business School students, and developed into a wellness brand featured in Glamour, New Beauty, Well + Good, Fast Company and The Huffington Post.

I

Investor

ICE Angels

Dec 2012 - Jul 2015 (2 years 8 months)

ICE Angels is Australasia's largest angel investment network. Screening Committee Member for 2013.

K

President

KENZI MANAGEMENT

Jan 2011 - Dec 2016 (6 years)

Private global investment vehicle. Direct investments in early-mid stage startups, as well as LP investments in venture, private equity and hedge funds. Active investments in US, Singapore, Europe and New Zealand.

C

Graduate Research Fellow

Columbia University Medical Center

Jan 2007 - Nov 2010 (3 years 11 months)

Executed a genome-wide RNAi screen of 16,000+ genes to identify 245 novel genes with a role in neuronal cell fate. The results, published in top peer-reviewed journals and presented at national and international conferences, help further our understanding of neural fate specification.

H

HHMI Undergraduate Research Fellow

Howard Hughes Medical Institute

May 2004 - Aug 2004 (4 months)

Made key discovery that shed light in the current understanding of the pathogenesis of Mucolipidosis IV -a debilitating orphan disease.

A

R&D and Technical Service Support Intern

Avery Dennison Chemical Division

Jun 2003 - May 2004 (1 year)

Supported product adjustment and new product development of a wide variety of emulsion and solvent based acrylic polymers in response to customer needs.

Enke Bashllari

About

Detail

Timeline

Résumé